Heart surgery risk for chronically ill patients may be explained by cell aging
NCT ID NCT07389785
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This research program studies why people with multiple long-term conditions like kidney or lung disease are more likely to suffer organ damage after heart surgery. Researchers will analyze existing data from over 3,000 patients to understand how aging-related changes in heart cells increase vulnerability. The goal is to identify potential drug targets that could protect organs during surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify new drug targets to protect organs during heart surgery, especially for people with multiple long-term conditions.
- What could go wrong
- This is an observational study using existing data, not a clinical trial testing a treatment. It may not lead to any new therapies, and findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGEING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Leicester
Leicester, Leicester, LE1 7RH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could continuing a common heart drug before surgery save lives?
- Could waking up in the operating room speed heart surgery recovery?
- Can a simple frailty check predict how well seniors recover from heart surgery?
- Could a simple scheduling change ease heart surgery nerves?
- Calcium timing during bypass may cut need for heart drugs
- Heart surgery recovery gets a wireless watchdog